October 13, 2016
October 13, 2016 —
The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program.
October 12, 2016
October 12, 2016 —
Researchers at University of California San Diego School of Medicine have confirmed that mutation-caused dysfunction in a process cells use to transport molecules within the cell plays a previously suspected but underappreciated role in promoting the heritable form of Alzheimer’s disease (AD), but also one that might be remedied with existing therapeutic enzyme inhibitors.
October 11, 2016
October 11, 2016 —
Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.
October 11, 2016
October 11, 2016 —
A surgical team at UC San Diego Health has completed the first series of operations with a novel surgical system that can remove a diseased gallbladder through a single incision hidden in the belly button.
October 11, 2016
October 11, 2016 —
Professor of Cellular and Molecular Medicine Pradipta Ghosh, second guest in the series, will address “The Herculean Task of Killing Cancer Cells: Spare the Heads of Hydra; Strike the Heart,” at 4 p.m. on Tuesday, October 18, in the Roth Auditorium at the Sanford Consortium for Regenerative Medicine.
October 4, 2016
October 4, 2016 —
Physician-scientists with Moores Cancer Center at UC San Diego Health have been leading the way in pancreatic cancer care by investigating new therapies as well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed to transform outcomes for patients with pancreatic cancer.
October 4, 2016
October 4, 2016 —
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
October 3, 2016
October 3, 2016 —
Researchers at University of California San Diego School of Medicine discovered a pattern of microbes indicative of IBD in dogs. With more than 90 percent accuracy, the team used that information to predict which dogs had IBD. However, they also determined that the gut microbiomes of dogs and humans are not similar enough to use dogs as animal models for humans with this disease. The study is published October 3 in Nature Microbiology.
October 3, 2016
October 3, 2016 —
Sports journalist and University of California San Diego alumnus Mark Johnson will take guests inside the metaphorical locker room to share the real dope on doping in professional sports, the focus of his new book, published in July 2016.
October 2, 2016
October 2, 2016 —
Approximately 20 percent of all human cancers have mutations in a gene called KRAS. KRAS-mutant cancers are among the most difficult to treat, with poor survival and resistance to chemotherapy. Researchers at University of California San Diego School of Medicine and Moores Cancer Center used microRNAs to systematically inhibit thousands of other genes to find combinations that are specifically lethal to cancer cells driven by a KRAS mutation.
